DistrictD

Lupin and Natco Pharma Receive US FDA Nod for Cancer Drug Generic

Lupin, in partnership with Natco Pharma, has received approval from the United States Food and Drug Administration (FDA) for their generic Eribulin Mesylate Injection.
This drug is a bioequivalent to Eisai's Halaven® Injection and is used to treat certain cases of metastatic breast cancer and liposarcoma, opening up a market with estimated annual sales of USD 43.7 million in the U.S.

Wockhardt's Novel Antibiotic 'Zaynich' Gets US FDA Approval

Wockhardt has received approval from the US FDA for its new antibiotic, ZAYNICH™ (cefepime and zidebactam), for treating complicated urinary tract infections.
This is a significant development as it is a new chemical entity developed by the Indian pharmaceutical company to combat drug-resistant bacteria, giving it access to a substantial global antibiotics market.

Bank of Baroda Announces Senior Management Reshuffle

Bank of Baroda has undertaken a significant restructuring of its senior management team, effective June 4, 2026.
The changes include new leadership appointments in the areas of IT projects, IT operations, and financial inclusion and CSR, signaling a strategic focus on strengthening its technological infrastructure and social impact initiatives.

Rajesh Exports Faces SEBI Scrutiny Over Alleged Revenue Misrepresentation

The Securities and Exchange Board of India (SEBI) has issued an interim order against Rajesh Exports, alleging significant misrepresentation of its revenue, amounting to approximately ₹15.15 trillion between FY21 and FY25.
The company's promoter has been barred from the securities market pending further investigation, and the stock hit its lower circuit following the news.
Rajesh Exports has issued a clarification stating that its financial reporting is correct and the issue stems from a "confusion and communication gap" with the regulator.

Aarti Industries Attains Top-Tier Sustainability Recognition

Aarti Industries has been awarded the prestigious EcoVadis Platinum Rating for 2026, placing it in the top 1% of companies assessed globally for sustainability performance.
This achievement, with a high score of 87 out of 100, is a significant milestone that can enhance its appeal to ESG-focused investors and global customers who prioritize sustainable and responsible supply chains.

Concord Biotech Secures US FDA Approval for Immunosuppressant

Concord Biotech has received US FDA approval for its Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for oral suspension.
This immunosuppressant drug is used to prevent organ rejection in transplant patients and targets a U.S. market estimated to be worth around USD 30 million.

Hinduja Global Solutions Recommends Final Dividend

The Board of Directors of Hinduja Global Solutions has recommended a final dividend of ₹5 per equity share for the financial year 2025-26.
This decision is subject to shareholder approval at the upcoming Annual General Meeting and provides a dividend yield for investors despite a challenging year for profitability.

Pilani Investment and Industries Corporation Proposes Dividend Payout

The board of Pilani Investment and Industries Corporation has recommended a dividend of ₹9 per equity share for the fiscal year ended March 31, 2026.
The proposed 90% dividend on the face value of each share is subject to shareholder approval at the next Annual General Meeting.

Gorilla Technology and Supermicro in Landmark AI Infrastructure Deal for India

Gorilla Technology has finalized a deal valued at approximately USD 2 billion with Super Micro Computer to supply AI infrastructure in India.
The agreement includes the delivery of a large number of advanced GPU cards and related equipment to support Gorilla's Yotta AI infrastructure project, signaling a major investment in India's AI capabilities.

Our Philosophy

We aim to revolutionize the way you analyse your investments

Democratization of Investment Analysis tools

Curated research data, financial models and analysis tools are available majorly to large financial institutions till date.

We believe that opening up these data sets and analytical tools will help everyone invest smartly.

Leverage Technology

Technology is at the core of everything we do at DistrictD!!

Our platform allows you to perform analysis on large data sets and generate easy-to-understand insights.

Data Privacy and complete User Control

We do not push ideas or recommendations to you. We allow you to test your ideas and scenarios directly with full control in your hands.

Your Data is completely secure as we are not in the business of selling ideas/recommendations.

No need of Excel for Investment Analysis

Our Web Platform allows you to access all relevant data, financial models, portfolio allocations and analysis tools on the go.

You don’t have to struggle through static data in Excel anymore.

Built for intelligent investors by former Research Analysts

Full suite of Financial & Operational Data, Models and Analytical tools

Interactive
Financial Models
Portfolio
Analyzer
Stock
Screeners
Industry
Data
Personalized
Environment

Interactive Financial Models

Access web models of top 1000 listed companies in India

Build your own estimates in an intuitive way

Perform sensitivity analysis and valuations using our in-built tools

Save your models / analysis and download in excel format

Try For Free

Portfolio Analyzer

Upload your Stock portfolio and generate meaningful insights

Portfolio Concentration
Attribution Analysis
Risk evaluation
Return expectations
And much more!!

Download Portfolio Analysis reports in PDF format

Try For Free

Stock Screeners

Create your own screeners with multiple levels of filters on Financials, Valuations, Stock Price Returns and other criteria

Predefined Stock screeners for direct use

Save filtering criteria for easy future use

Try For Free

Industry Data

Curated Industry Data with unique insights regarding competitive landscape and relative strengths of the companies within each Industry

Compare companies within the industry on multiple financial metrics

Try For Free

Personalized Environment

Calendar - Keep track of financial results, dividend announcements etc. for your followed companies

Personalization – Choose and set your own dashboard widgets, email updates, watchlists, NSE updates

Try For Free

Built for You

DistrictD has unique offerings for every type of user

Individuals

DistrictD platform provides data, proprietary financial models, analysis tools, screening tools portfolio analysis etc. in a singe platform.

Research

Screeners

Portfolio Analysis

IFAs

DistrictD platform provides data, proprietary financial models, analysis tools, screening tools portfolio analysis etc. in a singe platform.

Portfolio Reports

Research

Dedicated Support

Institutions

DistrictD platform provides data, proprietary financial models, analysis tools, screening tools portfolio analysis etc. in a singe platform.

Research Platforms Internal/Client facing

Wealth Management Analytics & Reprting

Fresh Intelligence. On the Hour.

Lupin and Natco Pharma Receive US FDA Nod for Cancer Drug Generic

Wockhardt's Novel Antibiotic 'Zaynich' Gets US FDA Approval

Bank of Baroda Announces Senior Management Reshuffle

Rajesh Exports Faces SEBI Scrutiny Over Alleged Revenue Misrepresentation

Aarti Industries Attains Top-Tier Sustainability Recognition

Concord Biotech Secures US FDA Approval for Immunosuppressant

Hinduja Global Solutions Recommends Final Dividend

Pilani Investment and Industries Corporation Proposes Dividend Payout

Gorilla Technology and Supermicro in Landmark AI Infrastructure Deal for India

Our Philosophy

Built for intelligent investors by former Research Analysts

Interactive Financial Models

Portfolio Analyzer

Stock Screeners

Industry Data

Personalized Environment

Built for You

Individuals

IFAs

Institutions